ask="3.77"
ask_size="500"
average_daily_volume="44008"
bid="1.00"
bid_size="200"
book_value="-0.93"
change="+0.11"
change_from_200_day_moving_average="-0.80"
change_from_50_day_moving_average="-0.43"
change_from_52_week_high="-2.70"
change_From_52_week_low="0.99"
change_in_percent="+4.10%"
close="2.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-2.06"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10398000"
high="2.99"
high_52_weeks="5.49"
last_trade_date="3/10/2017"
last_trade_price="2.79"
last_trade_size="799"
last_trade_time="4:00pm"
low="2.74"
low_52_weeks="1.80"
market_capitalization="65.93M"
moving_average_200_day="3.59"
moving_average_50_day="3.22"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="9.67"
open="2.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.37%"
percent_change_from_50_day_moving_average="-13.31%"
percent_change_from_52_week_high="-49.18%"
percent_change_from_52_week_low="+54.66%"
previous_close="2.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="27.68"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="0.89"
stock_exchange="NGM"
symbol="ONS"
volume="22933"
weeks_range_52="1.80 - 5.49"
